HMG-CoA
英
美
网络 还原酶; 限速酶; 还原酶抑制剂; 羟甲基戊二酰辅酶
双语例句
- Study of Hypolipidemic Mechanisms and Efficacy of the Compound Prescription of FTZ Based on the HMG-CoA Reductase
复方贞术调脂方基于HMG-CoA还原酶的降脂作用机制及药效物质基础研究 - The establishment of virtual screening models for the discovery of HMG-CoA reductase inhibitors
HMG-CoA还原酶抑制剂的虚拟筛选模型的建立 - The association of HMG-CoA reductase gene single nucleotide polymorphisms with coronary heart disease
HMG-CoA还原酶基因单核苷酸多态性与冠心病的关系 - Aim To seek and design new kinds of HMG-CoA reductase inhibitors.
目的寻找和设计新的HMG-CoA还原酶抑制剂。 - Objective To investigate the role of HMG-CoA reductase inhibitor, fluvastatin in the earlier cardiomyopathy of SD diabetic rats.
目的探讨氟伐他汀对糖尿病大鼠早期心肌病变的作用。 - Objective: To investigate the effect of simvastatin on the patients with diabetic nephropathy ( DN).
目的：评价HMG-CoA还原酶抑制剂辛伐他汀对血脂正常及血脂异常的糖尿病肾病（diabeticNephropathy，DN）防治效果，并探讨相应作用机制。 - Atorvastatin is a new generation of HMG-CoA reductase inhibitors ( blood lipid lowering agent of statins class).
阿托伐他汀钙是新一代羟甲戊二酰辅酶A（HMG-CoA）还原酶抑制剂（他汀类降血脂药）。 - Structure and Regulation of HMG-CoA Reductase
HMG-CoA还原酶的结构和调节 - Objective: To investigate the protective effects of angiotension II receptor antagonist Losartan and HMG-CoA reductase inhibitor Simvastatin on the kidneys of diabetic rats, and study their possible mechanisms.
目的：探讨血管紧张素Ⅱ受体拮抗剂氯沙坦和羟甲基戊二酰辅酶A（HMGCoA）还原酶抑制剂辛伐他汀对糖尿病大鼠肾脏病变的保护作用及其可能机制。 - Recent progress in understanding the molecular and cellular pathophysiology of Alzheimer's disease has suggested possible pharmacological interventions, such as treatment with secretase inhibitors, transition metal chelators, HMG-CoA reductase inhibitors and amyloid-β immunization.
随着对AD分子和细胞病理生理的进一步了解，又发展了医一些新的治疗方法，如分泌酶抑制剂、过渡金属元素螯合剂、HMGCoA还原酶抑制剂和β淀粉样蛋白疫苗等。 - 3D-QSAR study of statin inhibitors of HMG-CoA reductase
HMG-CoA还原酶抑制剂的3D-QSAR研究 - Expression of p38 MAPK Signal Transduction Pathway and Effect of HMG-CoA Reductase Inhibitor in Diabetic Nephropathy
p38MAPK信号转导通路在糖尿病肾病发病中的作用及HMG-CoA还原酶抑制剂的影响 - A comparison of inhibition of pravastatin on HMG-CoA reductase with enalapril and verapamil in SDR and SHR liver
普伐他汀、依那普利和维拉帕米对SDR和SHR肝脏HMG-CoA还原酶抑制作用的比较 - Study on lipemia modulator. Isolation and identification of HMG-CoA reductase inhibitor m-8614a and hm-2688b
血脂调节剂的研究&Ⅱ.HMG-CoA还原酶抑制剂M-8614A及MH-2688B的分离和鉴别 - Conclusion: Sodium propionate may decrease the activity of hepatic HMG-CoA reductase and suppress the synthesis of cholesterol.
结论：丙酸钠可以抑制肝脏HMG-CoA还原酶的活性，有效地减少肝脏胆固醇的合成。 - The objective product identified by qualitative HPLC analysis was trans-astaxanthin.
目标产物经HPLC定性分析，确定为反式虾青素。因此，以辛伐他汀等HMG-CoA还原酶抑制剂作为选择压力，对虾青素高产突变株的筛选上具有较好的筛分能力。 - Cloning and Sequence Analysis of HMG-CoA Reductase Gene in Porcine Liver
猪肝脏HMG-CoA还原酶基因的部分序列克隆及分析 - Objective: To investigate the effect of fluvastatin on the activity of the extracellular signal-regulated kinase ( ERK1/ 2) in renal cortex in diabetic rats.
目的：探讨HMG-CoA还原酶抑制剂氟伐他汀对实验性糖尿病大鼠肾皮质胞外调节蛋白激酶（ERK1/2）活性水平的影响。 - AIM: To evaluate the effects of fluvastatin, a hydroxymethylglutaryl-CoA ( HMG-CoA) reductase inhibitor, on the alterations of structure and function of resistant vessels in spontaneously hypertensive rats ( SHR).
目的：探讨氟伐他汀（HMG-CoA还原酶抑制剂）对自发性高血压大鼠阻力血管结构和功能的影响。 - Effects of HMG-CoA Reductase Inhibitors on Proliferation of Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats
HMG-CoA还原酶抑制剂对自发性高血压大鼠血管平滑肌细胞增殖的作用 - Effects of HMG-CoA Reductase Inhibitor on Proliferation and Differentiation of MCF-7 Human Breast Cancer Cells& Its Molecular Mechanisms
HMG-CoA还原酶抑制剂对MCF-7乳腺癌细胞增殖抑制和诱导分化作用及其机制的研究 - Role of intracellular calcium in proliferation inhibition of MCF-7 cells induced by HMG-CoA reductase inhibitor
细胞内Ca~（2+）在HMG-CoA还原酶抑制剂抑制MCF-7细胞增殖中的作用 - AIM To investigate the effect of OX-LDL and HMG-CoA reductase inhibitors simvastatin on PKC activity and cytosolic free Ca2+ in cultured human monocytes.
目的探讨OX－LDL及HMG－CoA还原酶抑制剂辛伐他汀对人单核细胞（Mo）表达蛋白激酶C（PKC）活性和胞浆内游离钙（〔Ca2＋〕i）浓度的影响。 - Effect of inhibitor of hmg_coa reductase on dyslipidemia in type 2 diabetes mellitus patients
HMG-CoA还原酶抑制剂对2型糖尿病病人的血脂影响 - Polymorphisms in the HMG-CoA Reductase Gene and Their Association with Coronary Heart Disease
HMG-GoA还原酶基因多态性与冠心病的相关性研究 - Effects of HMG-CoA Reductase Inhibitors on Connexin Expression between Proliferating Smooth Muscle Cells in the Rabbit Aterial Wall
HMG-CoA还原酶抑制剂对家兔血管平滑肌增殖中连接蛋白的影响 - Effects of HMG-CoA Reductase Inhibitor on the Expression of Low Density Lipoprotein Receptor in Liver of Nephrotic Rats
HMG-CoA还原酶抑制剂对肾病综合征大鼠肝脏低密度脂蛋白受体表达的影响 - Thus, the relationship between HMG-CoA reductase inhibitors and the Ras/ Raf/ ERK/ CREB signal pathway are worthy of further exploration.
由此，HMG-CoA还原酶抑制剂与Ras/Raf/ERK/CREB信号通路的关系值得深入探讨。